Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion in payments and royalties on sales.
Related Posts
Boston Celtics sold for $6.1 billion to group led by private equity executive Bill Chisholm
A group led by private equity executive Bill Chisholm is buying the NBA’s Boston Celtics for $6.1 billion.
European markets open lower as economic concerns persist
European markets are expected to start the new trading week in mixed territory Monday, as jitters persist over the global economy.
Citi upgrades this telecom stock poised to rally more than 40%
A number of catalysts may send lagging Lumen Technologies shares higher in the months ahead, according to Citi.